Breast cancer: Seno Medical hits 100th patient in Imagio pivotal trial

November 25, 2013 by Arezu Sarvestani

Texas-based Seno Medical enrolls its 1st 100 patients in a pivotal study of its Imagio opto-acoustic imaging system, which aims to avoid false-positives that result in unnecessary biopsies.

Breast cancer: Seno Medical hits 100th patient in Imagio imaging trial

Seno Medical Instruments touted the 100th patient enrolled in a pivotal clinical study of the company's Imagio system, an opto-acoustic breast imaging platform designed to help prevent unnecessary biopsies.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp